*Corresponding author:Wang Shouju, Department of Medical Imaging, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210000, China
Received: January 23, 2018; Published: February 02, 2018
To view the Full Article Peer-reviewed Article PDF
Invasive cystic hypersecretory hyperplasia (CHH) of the breast is very rare. The clinical manifestation of CHH iscystic masses, and it is not easy to determine its biological characteristics before an operation. A 54-year-old female patient was admitted with a cystic massin the left breastfor one week. After the operation, the pathology diagnosis was invasive CHC, and the postoperative period was uneventful.
Keywords: Invasive Cystic Hypersecretory Carcinoma (Chc); Breast Cancer; Breast-Conserving Surgery; Palpable Mass
Abbreviation: CHH: Cystic Hypersecretory Hyperplasia; CHC: Cystic Hypersecretory Carcinoma; TG: Thyro Globulin; TTF-1: Thyroid Transcription Factor-1; GATA3: GATA binding protein 3; ER: Estrogen Receptor; PR: Progesterone Receptor; HER-2: Human Epidermal growth factor Receptor-2